Pan Wang | Neuroscience | Best Researcher Award

Dr. Pan Wang | Neuroscience | Best Researcher Award

Postdoctoral Researcher at Affiliated First Hospital of Zhejiang University School of Medicine, China.

Dr. Pan Wang is a postdoctoral researcher at the Department of Pathology, Zhejiang University School of Medicine. With a background in human anatomy, embryology, and pathology, Dr. Wang’s research focuses on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s disease. His work explores molecular pathways, extracellular vesicles, and neurovascular mechanisms in disease pathogenesis and diagnosis.

Publication Profile

Scopus

Educational Details

  • Ph.D. in Human Anatomy and Embryology – China Medical University, China (2016-2020)

  • M.S. in Human Anatomy and Embryology – Jinzhou Medical University, China (2009-2012)

  • B.S. in Clinical Medicine – Jinzhou Medical University, China (2004-2009)

Professional Experience

Dr. Wang has extensive experience in neuropathology research. Since 2021, he has been a postdoctoral researcher at Zhejiang University, investigating spatial transcriptomics and disease biomarkers in Alzheimer’s and Parkinson’s disease. Before that, he worked as an Assistant Researcher in the Department of Neurobiology at Jinzhou Medical University (2012–2016), where he contributed to studies on synaptic dysfunction, neuroinflammation, and vascular pathology in neurodegenerative conditions.

Research Interest

  • Molecular mechanisms of Alzheimer’s & Parkinson’s disease

  • Neurovascular interactions and blood-brain barrier dysfunction

  • Role of extracellular vesicles in neurodegeneration

  • Spatial transcriptomics and precision diagnostics in neuropathology

Author Metrics

As of April 2025, Dr. Pan Wang has authored over 8 publications, with a total citation count exceeding 3,200 and an h-index of 25. These metrics reflect the impact and recognition of his research contributions in the scientific community.

Top Noted Publication

  • Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas

    • Journal: Neuron (2025)

    • DOI: 10.1016/j.neuron.2025.03.002

    • Summary: Investigates molecular mechanisms in the hippocampus using spatial transcriptomics to advance Alzheimer’s disease diagnostics.

  • α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis

    • Journal: Translational Neurodegeneration (2023)

    • DOI: 10.1186/s40035-023-00372-y

    • Summary: Identifies the role of astrocytic extracellular vesicles in the spread of α-synuclein and their potential as diagnostic markers in Parkinson’s disease.

  • Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease

    • Journal: Neural Regeneration Research (2021)

    • DOI: 10.4103/1673-5374.295349

    • Summary: Explores melatonin’s neuroprotective effects on microvascular dysfunction in Alzheimer’s disease.

  • Regulatory role of melatonin in Notch1 signaling pathway in cerebral cortex of Aβ(1-42)-induced Alzheimer’s disease rat model

    • Journal: Molecular Biology Reports (2023)

    • DOI: 10.1007/s11033-022-08213-3

    • Summary: Examines melatonin’s modulation of Notch1 signaling in Alzheimer’s pathology.

  • Effects of the genetic knockout of the β-1,3-galactosyltransferase 2 on spatial learning and neurons in the adult mouse hippocampus and somatosensory cortex

    • Journal: Neuroreport (2023)

    • DOI: 10.1097/wnr.0000000000001857

    • Summary: Investigates the impact of β-1,3-galactosyltransferase 2 knockout on cognitive functions and neurodevelopment.

  • Protective effect of melatonin on soluble Aβ1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus

    • Journal: Alzheimer’s Research & Therapy (2016)

    • DOI: 10.1186/s13195-016-0206-x

    • Summary: Demonstrates melatonin’s protective role against Aβ1-42-induced neurotoxicity.

  • Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson’s disease

    • Journal: Glia (2022)

    • DOI: 10.1002/glia.24109

    • Summary: Identifies VEGFA as a critical factor in blood-brain barrier dysfunction in Parkinson’s disease.

  • Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson’s Disease

    • Journal: Movement Disorders (2024)

    • DOI: [Pending]

    • Summary: Explores the gut-brain axis in Parkinson’s disease, focusing on erythrocytic α-synuclein interactions with the microbiome.

Conclusion

Dr. Pan Wang is a highly qualified candidate for the Best Researcher Award, given his impactful contributions to neuroscience, strong publication record, and high citation count. His expertise in neurodegenerative diseases and innovative research techniques positions him as a leading figure in his field.

To further strengthen his candidacy, expanding international collaborations, securing research funding, and taking on leadership roles would elevate his profile for top-tier research awards.

Omar Ahmed-Farid | Neuroscience | Neuroscience Impact Award

Assoc. Prof. Dr. Omar Ahmed-Farid | Neuroscience | Neuroscience Impact Award

Principal Investigator at National Organization for Drug Control and Research, Egypt.

Assoc. Prof. Dr. Omar Ahmed-Farid is a distinguished researcher and academic specializing in animal physiology and pharmaceutical analytics. With over 15 years of experience in drug regulation, physiological research, and chromatographic techniques, he has played a pivotal role in enhancing pharmaceutical quality control in Egypt. As a certified trainer, he has educated numerous professionals in advanced chromatography and analytical method development. His research interests lie in bioanalysis, drug metabolism, and enantiomeric purity assessment, making significant contributions to pharmaceutical sciences. Currently, he leads the Diagnostic Kits and Medical Supplies Administration at EDA, ensuring the highest standards of medical diagnostics and regulatory compliance.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • Ongoing (2020 – Present): Associate Professor of Animal Physiology

  • 2015 – 2020: Researcher in Animal Physiology

  • 2010 – 2015: Assistant Researcher in Animal Physiology

  • 2005 – 2010: An Assistant in Research of Animal Physiology

Professional Experience

Dr. Omar Ahmed-Farid is an esteemed researcher and associate professor specializing in animal physiology, with extensive expertise in chromatographic techniques and pharmaceutical analysis. Currently serving as the Head of Diagnostic Kits and Medical Supplies Administration at the Egyptian Drug Authority (EDA), he is responsible for overseeing regulatory and quality assurance processes for medical diagnostics.

Previously, he held key managerial positions, including serving as the Technical Manager at the Reference Lab (EDA) (2020–2022) and Technical Manager at the Physiology Department, National Organization for Drug Control and Research (NODCAR) (2015–2020). His earlier roles at NODCAR (2006–2015) involved progressive responsibilities in physiological research and pharmacokinetics.

Dr. Ahmed-Farid is also a certified trainer in chromatographic instrumentation and has conducted numerous professional development courses on HPLC, GC, method development, bioanalysis, and pharmaceutical quantitative analysis. His training programs, offered through the Center for Continuing Professional Development (CPD), have significantly contributed to capacity building in pharmaceutical sciences.

Research Interest

Dr. Ahmed-Farid’s research focuses on animal physiology, pharmacokinetics, chromatographic method development, and bioanalysis. He has a strong interest in the quantitative analysis of drugs in biological matrices, enantiomeric purity assessment, and optimization of chromatography techniques for pharmaceutical applications. His work bridges the gap between analytical chemistry, physiology, and drug metabolism, contributing to advancements in pharmaceutical quality control and regulatory sciences.

Author Metrics & Contributions

Dr. Ahmed-Farid has authored and co-authored several peer-reviewed publications in high-impact scientific journals. His research contributions are widely recognized in the fields of pharmaceutical sciences, analytical chemistry, and animal physiology. His publications and citation metrics demonstrate his influence in chromatographic analysis and pharmacokinetics.

Top Noted Publication

Dr. Omar Ahmed-Farid has made significant contributions to biomedical research, pharmaceutical sciences, and animal physiology, with a focus on bioactive materials, pharmacological interventions, and nutritional physiology. His work is well-cited, demonstrating its impact in multiple scientific fields.

  1. Hyaluronic Acid/Na-Alginate Films as Bioactive Wound Dressings

    • European Polymer Journal (2018) – Citations: 113

    • Development of topical bioactive wound dressings using hyaluronic acid and sodium alginate, enhancing wound healing properties.

  2. Microalgae in Poultry Nutrition

    • Animals (2020) – Citations: 107

    • Investigated dietary microalgae in broiler chickens, assessing growth performance, antioxidant status, and meat quality.

  3. Curcumin Nano-Emulsion for Reproductive Health

    • Journal of Biomedical Science (2017) – Citations: 96

    • Explored curcumin nano-emulsion’s impact on spermatogenesis and sperm motility, particularly in protein-deficient diets.

  4. Protective Effect of L-Carnitine & L-Arginine Against Oligospermia

    • Andrologia (2018) – Citations: 90

    • Examined busulfan-induced oligospermia and the potential therapeutic role of L-carnitine and L-arginine.

  5. Sustainable Encapsulation of Guava Leaf Extracts

    • ACS Sustainable Chemistry & Engineering (2019) – Citations: 89

    • Developed an eco-friendly encapsulation system for guava leaf extract, improving multifunctional textile finishing.

  6. Lidocaine/β-Cyclodextrin Drug Delivery System

    • European Polymer Journal (2018) – Citations: 66

    • Investigated the inclusion complex of lidocaine with β-cyclodextrin for enhanced drug delivery.

  7. Silymarin’s Protective Role in Dementia

    • Open Access Macedonian Journal of Medical Sciences (2018) – Citations: 60

    • Studied silymarin’s neuroprotective effects in scopolamine-induced dementia.

  8. Hepatoprotective Effects Against Methotrexate-Induced Toxicity

    • Asian Pacific Journal of Tropical Medicine (2017) – Citations: 56

    • Evaluated natural hepatoprotective agents, including Balanites aegyptiaca extract and melatonin.

  9. Antidepressant Effect of Cerebrolysin

    • Chemico-Biological Interactions (2021) – Citations: 51

    • Provided behavioral, biochemical, and molecular evidence of cerebrolysin’s efficacy in depression treatment.

  10. Dietary Zinc Oxide Nanoparticles and Antioxidant Gene Expression

  • BMC Veterinary Research (2020) – Citations: 46

  • Examined zinc oxide nanoparticles’ effect on oxidative stress and immune responses in Japanese quails.

Conclusion

Assoc. Prof. Dr. Omar Ahmed-Farid is a strong candidate for the Research for Neuroscience Impact Award due to his contributions to neuropharmacology, neuroprotection, and therapeutic advancements in cognitive disorders. His interdisciplinary expertise in drug metabolism, chromatographic techniques, and bioanalysis enhances his research’s relevance in neurological health and therapeutic interventions. Strengthening his direct neuroscience applications and global collaborations would further solidify his recognition as a leading neuroscientist.